article thumbnail

IV Robotics and the Latest USP Revisions

Omnicell

The latest revisions, which take effect November 1, 2023, exempt some robotic devices from surface sampling after every batch of Category 3 compounded sterile products (CSPs) and instead allow users of self-enclosed robotic devices to surface sample once per day. Subscribe today.

article thumbnail

Manual IV Compounding – a Potential Recipe for Disaster?

Omnicell

Simply put: manual IV compounding is dangerous—there’s just too much risk for things to go wrong. When outsourcing IV compounding, many health systems experience significant delays, long turnaround times, and unexpected closure of vendors that can leave hospitals feeling helpless.

article thumbnail

Autonomous Pharmacy Drives Efficient Hospitals, Safer Patients

Omnicell

One key area was in sterile compounding of IVs – a big risk area – in which a dosing error could have serious consequences. Read this APNews.com article to learn more. In the typical hospital pharmacy, IVs are manually prepared by pharmacy technicians and then manually checked by pharmacists.